Results 11 to 20 of about 91,559 (219)

Diarrheagenic and ESBL Potential of Escherichia coli From Publicly Shared Common Touch Surfaces. [PDF]

open access: yesMicrobiologyopen
Frequently touched surfaces (FTS) in public areas play a critical role in the transmission of infectious pathogens, including drug‐resistant bacteria. In this study, we identified multidrug‐resistant, ESBL‐producing diarrheagenic Escherichia coli on FTS.
Arif M   +7 more
europepmc   +2 more sources

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities

open access: yesBiomedicines, 2023
The rise of antimicrobial resistance, particularly from extended-spectrum β-lactamase producing Enterobacteriaceae (ESBL-E), poses a significant global health challenge as it frequently causes the failure of empirical antibiotic therapy, leading to ...
Asmaul Husna   +7 more
semanticscholar   +1 more source

Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals

open access: yesAntibiotics, 2023
Animals have been identified as potential reservoirs and vectors of resistance genes, with studies showing that Gram-negative bacteria can acquire resistance through the horizontal transmission of resistance genes on plasmids.
Chien-Hao Tseng   +2 more
semanticscholar   +1 more source

The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community.

open access: yesJournal of Antimicrobial Chemotherapy, 2021
OBJECTIVES Intestinal colonization by ESBL Escherichia coli and its association with community-acquired MDR infections is of great concern. This review determined the worldwide prevalence of human faecal ESBL E.
Y. Bezabih   +6 more
semanticscholar   +1 more source

Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis

open access: yesJAC-Antimicrobial Resistance, 2022
Objectives The widespread intestinal carriage of ESBL-producing Escherichia coli (ESBL E. coli) among both patients and healthy individuals is alarming.
Y. Bezabih   +12 more
semanticscholar   +1 more source

Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples

open access: yesScientific Reports, 2021
Nowadays, increasing extended-spectrum β-lactamase (ESBL)-producing bacteria have become a global concern because of inducing resistance toward most of the antimicrobial classes and making the treatment difficult.
M. Gharavi   +5 more
semanticscholar   +1 more source

Genetic Determinants of Resistance among ESBL-Producing Enterobacteriaceae in Community and Hospital Settings in East, Central, and Southern Africa: A Systematic Review and Meta-Analysis of Prevalence

open access: yesThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2021
Background The world prevalence of community and hospital-acquired extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing tremendously.
O. G. Onduru   +3 more
semanticscholar   +1 more source

Existence of Multiple ESBL Genes among Phenotypically Confirmed ESBL Producing Klebsiella pneumoniae and Escherichia coli Concurrently Isolated from Clinical, Colonization and Contamination Samples from Neonatal Units at Bugando Medical Center, Mwanza, Tanzania

open access: yesAntibiotics, 2021
The proportions and similarities of extended-spectrum β-lactamase (ESBL) producing K. pneumoniae (ESBL-KP) and E. coli (ESBL-EC) carrying multiple ESBL genes is poorly known at our setting.
Vitus Silago   +8 more
semanticscholar   +1 more source

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).

open access: yesClinical Infectious Diseases, 2020
BACKGROUND Antimicrobial-resistant infections are commonly encountered in US hospitals and result in significant morbidity and mortality. This guidance document provides recommendations for the treatment of infections caused by extended-spectrum β ...
P. Tamma   +5 more
semanticscholar   +1 more source

ESBL plasmids in Klebsiella pneumoniae: diversity, transmission and contribution to infection burden in the hospital setting

open access: yesmedRxiv, 2021
Background Resistance to third-generation cephalosporins, often mediated by extended-spectrum beta-lactamases (ESBLs), is a considerable issue in hospital-associated infections as few drugs remain for treatment.
J. Hawkey   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy